Cell Signaling and Tumorigenesis
Section Leader
James Robinson, Ph.D.
Assistant Professor

Dr. Robinson is an Assistant Professor at the University of Minnesota and a Member of the Masonic Cancer Institute. He received his Ph.D. in Tumor Biology from Queen Mary, University of London and postdoctoral training at the Huntsman Cancer Institute in Salt Lake City, Utah. His research specializes in the cell signaling events that drive tumor growth and resistance to targeted therapies. He is the recipient of an American Cancer Society, Research Scholar Grant to determine and validate Resistance Mechanisms to targeted therapy in Melanoma and a National Cancer Institute Pathway to Independence Award to study the role of tumor microenvironment interactions in cancer. Dr. Robinson is also investigating the mechanistic link between IDH and H3.3 mutations in the development of malignant gliomas. His long-term goals include the development a systematic approach for the identification and validation of stromal signaling pathways responsible for the promotion, maintenance, metastasis, and chemoresistance of cancer.